Altimmune Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Altimmune Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ALT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001326190
Board of directors
-
Catherine A. Sohn · DirectorSince 2023
-
David Drutz · DirectorSince 2023
-
Diane Jorkasky · DirectorSince 2023
-
John Gill · DirectorSince 2023
-
Klaus Schafer · DirectorSince 2023
-
Mitchel Sayare · DirectorSince 2023
-
Philip Hodges · DirectorSince 2023
-
Vipin K. Garg · Director · President and CEOSince 2023
-
Wayne Pisano · DirectorSince 2023
Chief executives
Vipin K. Garg
· President and CEO
Dates unknown
Board connections
1 of this board's directors also sit on 1 other board.
- via Catherine A. Sohn
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 19, 2024 | David Drutz Director | Option exercise | +20,000 | $2.60 | $52,000 |
| Aug 19, 2024 | David Drutz Director | Open-market sale | −7,827 | $6.93 | $54,241 |
| Aug 19, 2024 | David Drutz Director | Option exercise | +21,750 | $2.50 | $54,375 |
| Aug 19, 2024 | David Drutz Director | Open-market sale | −8,184 | $6.88 | $56,306 |
| Jul 31, 2024 | Shutterly Andrew Officer (Acting Chief Financial Officer) | Grant or award | +1,259 | $5.41 | $6,811 |
| Jul 31, 2024 | Roberts M Scot Officer (Chief Scientific Officer) | Grant or award | +650 | $5.41 | $3,517 |
| Jul 31, 2024 | Jordt Raymond M Officer (Chief Business Officer) | Grant or award | +917 | $5.41 | $4,961 |
| Jul 31, 2024 | Harris Matthew Scott Officer (Chief Medical Officer) | Grant or award | +1,486 | $5.41 | $8,039 |
| Feb 2, 2024 | Roberts M Scot Officer (Chief Scientific Officer) | Option exercise | +7,775 | — | — |
| Feb 2, 2024 | Harris Matthew Scott Officer (Chief Medical Officer) | Option exercise | +7,775 | — | — |
| Feb 2, 2024 | Vipin K. Garg Director, Officer (President and CEO) | Option exercise | +18,950 | — | — |
| Feb 2, 2024 | Roberts M Scot Officer (Chief Scientific Officer) | Shares withheld for tax | −2,330 | $9.32 | $21,716 |
| Feb 2, 2024 | Harris Matthew Scott Officer (Chief Medical Officer) | Shares withheld for tax | −2,332 | $9.32 | $21,734 |
| Feb 2, 2024 | Vipin K. Garg Director, Officer (President and CEO) | Shares withheld for tax | −8,376 | $9.32 | $78,064 |
| Feb 1, 2024 | Roberts M Scot Officer (Chief Scientific Officer) | Option exercise | +6,166 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.